BU-NOT-SET

CONTACT US
A CDMO’s insight into the pharma M&A landscape
  • Industry trends
Eyes
Insight
Recipharm’s continuous global support throughout the COVID-19 pandemic
  • Industry trends
Eyes
Insight
Is outsourcing the most viable pathway for innovators?
  • Manufacturing
Meeting
Insight
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Insight
  • Drug product
  • Industry trends
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
Insight
  • Industry trends
  • Manufacturing
A well-equipped CDMO for OSD contract manufacturing
Insight
  • Analytical chemistry
  • Industry trends
Optimising efficiency with technological innovation in analytical testing
Brochure
  • Biologics
Progress your biologic with Advanced Bio comprehensive services
Insight
  • Biologics
Innovation & leadership across the advanced therapy space
Insight
  • Biologics
Overcoming oncolytic virus obstacles with the help of a CDMO partnership
Webinar
  • Biologics
Webinar: Beyond borders: Navigating global scale-up for viral-based therapies
eBook
  • Drug product
Choosing the right container for your sterile drug product
White paper
  • Biologics
Cell and virus banking in OV development and manufacturing